Citigroup Inc Protara Therapeutics, Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 12,945 shares of TARA stock, worth $50,873. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,945Holding current value
$50,873% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
29.8MCall Options Held
49.5KPut Options Held
181K-
Ra Capital Management, L.P. Boston, MA3.4MShares$13.4 Million0.29% of portfolio
-
Janus Henderson Group PLC London, X02.27MShares$8.93 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.25MShares$8.84 Million0.02% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A62.09MShares$8.21 Million0.02% of portfolio
-
Opaleye Management Inc. Boston, MA1.83MShares$7.17 Million1.88% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $44.3M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...